|
1 Chinese Medical Gastroenteric Organization. Suggestion to diagnosis and therapy standard on IBD. Chin Digest J, 2001, 21(4)：236.[中华医学会消化病分会．对炎症性肠病诊断治疗规范的建议. 中华消化杂志，2001, 21(4)：236.]
|
|
2 Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down? World J Gastroenterol, 2006, 12: 6102–6108.
|
|
3 Turunen P, Kolho KL, Auvinin A, et al. Incidence of inflammatory bowel disease in Finnish children. Infalmm Bowel Dis, 2006, 12: 677–683.
|
|
4 Ahmed M, Davies IH, Hood K, et al. Incidence of paediatric inflammatory bowel disease in South Wales. Arch Dis Child, 2006, 91: 344–345.
|
|
5 Ketil S, Jorgen J, Beint SB, et al. Pediatric inflammatory bowel disease in Southeastern Norway: A five–year follow–up study. Digestion, 2004, 70: 226–230.
|
|
6 Levine A, Kugathasan S, Annese V, et al. Pediatric onset Crohn's colitis is characterized by genotype–dependent age–related susceptibility. Inflamm Bowel Dis, 2007, 13: 1509–1515.
|
|
7 Su Y, Zhen H, Shen FE. Clinical analysis of 45 IBD cases in children. Pract Pediatr Clin J, 2003, 5(18): 341–343.[苏颖，郑华，申芳娥. 儿童炎症性肠病45例临床分析. 实用儿科临床杂志，2003, 5(18): 341–343.]
|
|
8 Motil KJ, Grand RJ, Davis–Kraft L, et al. Growth failure in children with inflammatory bowel disease: A prospective study. Gastroenterology, 1993, 105: 681–691.
|
|
9 Weinstein TA, Levine M, Pettei MJ, et al. Age and family history at presentation of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 2003, 37: 609–613.
|
|
10 Pinsk V, Lemberg DA, Grewal K, et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol, 2007, 102: 1077–1083.
|
|
11 Castellaneta S, Afzal N, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 2004, 39: 257–261.
|
|
12 Mamula P, Telega GW, Markowitz JE, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol, 2002, 97(8): 2005–2010.
|
|
13 Robert M, Tang L, Hao L, et al. Patterns of inflammation in mucosal biopsies of ulcerativecolitis–perceived differences in pediatric populations are limited to children younger than ten years. Am J Surg Pathol, 2004, 28：183–189.
|
|
14 Washington KG, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol, 2002, 26: 1441–1449.
|
|
15 Farmer RG, Easley KA, Rankin GB, et al. Clinical patterns, natural history, and progression of ulcerative colitis: A long–term follow–up of 1 116 patients. Dig Dis Sci, 1993, 105: 681–691.
|
|
16 Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease: Epidemiology and management in an English general practice population. Aliment Pharmacol Ther, 2000, 14: 1553–1559.
|
|
17 Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: A statewide population–based study. J Pediatr, 2003, 143: 525–531.
|
|
18 Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Chlid, 2003, 38: 302–307.
|
|
19 Auvin S, Molinie F, Gower–Rousseau C, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: A prospective population–based study in Northern France (1988–1999). J Pediatr Gastroenterol Nutrit, 2005, 41(1): 49–55.
|
|
20 Ceballos C. Growth and early onset inflammatory bowel disease. Gastroenterol Nurs, 2008, 31: 101–104.
|
|
21 Nasim S, Dorsey B. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia. Pediatrics, 2007, 119: 193–199.
|
|
22 Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis, 2002, 8: 325–329.
|
|
23 Yoram E, Zandra L, Naser T. The diagnostic accutacy of serologic markers in children with IBD. J Clin Gastroenterol, 2005, 39: 670–673.
|
|
24 Martin C. Pediatric inflammatory bowel disease imaged with Tc–99m white blood cells. Clin Nuclear Med, 2000, 25(9): 708–715.
|
|
25 Lemberg DA, Issenman RM, Cawdron R, et al. Positron Emission Tomography in the investigation of pediatric inflammatory bowel disease. Inflammat Bowel Dis, 2005, 11(8): 733–738.
|
|
26 Borthne AS, Abdelnoor M, Rugtveit J, et al. Bowel magnetic resonance imaging of pediatric patients with oral mannitol MRI compared to endoscopy and intestinal ultrasound. Eur Radiol, 2006, 16: 207–214.
|
|
27 Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology, 2006, 130(3): 935–939.
|
|
28 Gisbert JP, Nino P, Rodrigo L, et al. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: Long–term follow–up study of 394 patients. Am J Gastroenterol, 2006, 12: 2769–2776.
|
|
29 Sergio F, Manila C, Stefano M, et al. Efficacy of long–term treatment with thalidomide in children and young adults with Crohn disease: Prelininary results. J Pediatr Gastroenterol Nutr, 2001, 32: 178–118.
|
|
30 Lazzerini M, Martelossi S, Marchetti F, et al. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: Long–term results. Aliment Pharmacol Therapeut, 2007, 25: 419–427.
|